Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Miles C. Andrews et al.|Cell Research|2019Cited by 246
Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4 <sup>+</sup> T cellsArnaud Pommier, Armelle Prévost‐Blondel, A. Audemard et al.|Proceedings of the National Academy of Sciences|2013Cited by 65